Two academics suggest that loans financed by the private sector could be one way to help patients cover the cost of expensive, curative pharmaceuticals. Think mortgages.
Private insurers billed California $387.5 million to treat just 3,624 patients with new medications for hepatitis C. The people are covered by the state's Medicaid program.
Effective treatments for hepatitis C cost as much as $95,000. Medicaid in many states, including Indiana, is mostly limiting the drugs' use to very advanced cases. ACLU of Indiana is suing the state.
Medicare insurance plans for drugs vary widely in the medicines they cover. For 2016, some patients who pick the wrong plan could pay nearly $12,000 out of pocket annually for a single drug.
About 15 percent of people in prison are infected with hepatitis C. Screening and treating inmates would save $750 million over 30 years and prevent many new cases in the general public.
The agency that administers Obamacare in California moved to make expensive medicines more affordable in 2016. In most plans, patients will pay no more than $150 or $250 a month.
The rise in heroin use in the town of Turners Falls, Mass., has led to another problem: a proliferation of discarded hypodermic needles. Police can't keep up, so they've asked residents to help.
The U.S. epidemic of injected-opioid use could lead to more severe outbreaks of HIV and hepatitis C, like those now occurring in Indiana, the Centers for Disease Control And Prevention says.